Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 9;10(12):e0144116.
doi: 10.1371/journal.pone.0144116. eCollection 2015.

Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance

Affiliations

Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance

Christian-Alexandre Castellano et al. PLoS One. .

Abstract

Objective: To investigate whether cerebral metabolic rate of glucose (CMRglu) is altered in normal weight young women with polycystic ovary syndrome (PCOS) who exhibit mild insulin resistance.

Materials and methods: Seven women with PCOS were compared to eleven healthy female controls of similar age, education and body mass index. Regional brain glucose uptake was quantified using FDG with dynamic positron emission tomography and magnetic resonance imaging, and its potential relationship with insulin resistance assessed using the updated homeostasis model assessment (HOMA2-IR). A battery of cognitive tests was administered to evaluate working memory, attention and executive function.

Results: The PCOS group had 10% higher fasting glucose and 40% higher HOMA2-IR (p ≤ 0.035) compared to the Controls. The PCOS group had 9-14% lower CMRglu in specific regions of the frontal, parietal and temporal cortices (p ≤ 0.018). A significant negative relation was found between the CMRglu and HOMA2-IR mainly in the frontal, parietal and temporal cortices as well as in the hippocampus and the amygdala (p ≤ 0.05). Globally, cognitive performance was normal in both groups but scores on the PASAT test of working memory tended to be low in the PCOS group.

Conclusions: The PCOS group exhibited a pattern of low regional CMRglu that correlated inversely with HOMA2-IR in several brain regions and which resembled the pattern seen in aging and early Alzheimer's disease. These results suggest that a direct association between mild insulin resistance and brain glucose hypometabolism independent of overweight or obesity can exist in young adults in their 20s. Further investigation of the influence of insulin resistance on brain glucose metabolism and cognition in younger and middle-aged adults is warranted.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Brain regions with significantly lower glucose uptake in the PCOS compared to the Control group.
All results were FDR-corrected for multiple comparisons (p ≤ 0.05).
Fig 2
Fig 2. Scatter plot of calculated insulin resistance based on homeostatic model assessment (HOMA2-IR) and average cerebral metabolic rate of glucose (CMRglu; μmol/100 g/min) in AD-vulnerable brain regions.

References

    1. Blázquez E, Velázquez E, Hurtado-Carneiro V, Ruiz-Albusac JM (2014) Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer’s disease. Front Endocrinol (Lausanne) 5: 1–21. - PMC - PubMed
    1. Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, et al. (2002) The role of insulin in human brain glucose metabolism: An 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51: 3384–3390. - PubMed
    1. Hirvonen J, Virtanen KA, Nummenmaa L, Hannukainen JC, Honka MJ, Bucci M, et al. (2011) Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes 60: 443–447. 10.2337/db10-0940 - DOI - PMC - PubMed
    1. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al. (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch Neurol 69: 29–38. 10.1001/archneurol.2011.233 - DOI - PMC - PubMed
    1. Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, et al. (2011) Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 27: 3–20. 10.1016/j.nut.2010.07.021 - DOI - PMC - PubMed

Publication types